Replies to post #314437 on Avid Bioservices Inc (CDMO)

[biopharm]

The first Oct 2013 link traces back to a post by djohn, where most were astonished to even hear how it was inferred that Bexion discovered a biomarker as we all know ...Phosphatidylserine

...these puzzle pieces have been sitting for quite some time...interesting times indeed

University of Cincinnati (UC) researchers have discovered a biomarker, known as phosphatidylserine (PS), for pancreatic cancer that could be effectively targeted, creating a potential therapy for a condition that has a small survival rate.These findings, being published in the Oct. 4, 2013, online edition of PLOS ONE, also show that the use of a biotherapy consisting of a lysosomal protein, known as saposin C (SapC), and a phospholipid, known as dioleoylphosphatidylserine (DOPS), can be combined into tiny cavities, or nanovesicles, to target and kill pancreatic cancer cells.
..
..
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=92700966